Last reviewed 2026-04-23 · How we verify

Solution for Peritoneal Dialysis

This solution helps remove waste products from the blood by exchanging fluids in the peritoneal cavity.

This solution helps remove waste products from the blood by exchanging fluids in the peritoneal cavity. Used for Peritoneal dialysis for patients with end-stage renal disease.

At a glance

Mechanism of action

The solution contains electrolytes and glucose that help draw excess fluids and waste products from the blood into the peritoneal cavity, where they can be removed through the dialysis process.

Approved indications

• Peritoneal dialysis for patients with end-stage renal disease

Common side effects

• Peritonitis
• Electrolyte imbalance
• Hypotension

Key clinical trials

• Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. (PHASE3)
• Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients (PHASE4)
• Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan (PHASE1, PHASE2)
• A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) (PHASE3)
• Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children With End-stage Kidney Disease From Low-resource Settings (NA)
• Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients (NA)
• Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution (PHASE4)
• Peritoneal Ultrafiltration in Cardio Renal Syndrome. (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.